Physician profile
Christopher Maender
NPI 1376763227
$615.23
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.31 · 2020: $34.58 · 2021: $94.50 · 2022: $390.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $268.80 | 2022 | |
| Stryker Corporation | $113.22 | 2020-2021 | |
| Depuy Synthes Sales INC. | $82.82 | 2022 | |
| Smith+Nephew, INC. | $75.81 | 2019 | |
| Orthofix Medical, INC. | $37.70 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $21.02 | 2022 | |
| Pacira Therapeutics, INC. | $15.86 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Maender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.